
Form 144 Axsome Therapeutics For: 26 February
Source link
ALX Oncology Describes Pivotal Trial Preparation by Late 2026 with Expanded ASPEN-09 Study and $150M Funding
ALX Oncology Describes Pivotal Trial Preparation by Late 2026 with Expanded ASPEN-09 Study and $150M Funding Source link




